Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | P4HB | P07237 | 4/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.55 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.54 |
| ▸ | BCHE | P06276 | 6/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 5/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11451254 | 1.00 | KMT2A (0.62) | KMT2AMEN1P4HBMAOBMAOA | |
| SCHEMBL30384328 | 1.00 | KMT2A (0.62) | KMT2AMEN1P4HBMAOBMAOA | |
| SCHEMBL25189336 | 0.92 | KMT2A (0.68) | KMT2AMEN1MAOBMAOANPC1 | |
| SCHEMBL11452481 | 0.90 | KMT2A (0.65) | KMT2AMEN1MAOBMAOANPC1 | |
| SCHEMBL11452485 | 0.90 | KMT2A (0.65) | KMT2AMEN1MAOBMAOANPC1 | |
| SCHEMBL30383113 | 0.90 | KMT2A (0.65) | KMT2AMEN1MAOBMAOANPC1 | |
| SCHEMBL25195879 | 0.88 | MEN1 (0.64) | KMT2AMEN1P4HBMAOBMAOA | |
| SCHEMBL31233321 | 0.88 | MEN1 (0.64) | KMT2AMEN1P4HBMAOBMAOA | |
| SCHEMBL25212073 | 0.86 | KMT2A (0.76) | KMT2AMEN1MAOBMAOANPC1 | |
| SCHEMBL25192238 | 0.86 | KMT2A (0.76) | KMT2AMEN1MAOBMAOANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4190671-A | ANTIINFLAMMATORY, ANTIALLERGENIC, ANTIULCER | BIOREX LABORATORIES LIMITED (GB) | 1980-02-26 | — | — | US | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-4190671-A | ANTIINFLAMMATORY, ANTIALLERGENIC, ANTIULCER | BIOREX LABORATORIES LIMITED (GB) | 1980-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | KMT2A 2792/4885MEN1 3367/4885P4HB 552/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | KMT2A 3188/4885MEN1 2457/4885P4HB 469/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | KMT2A 3188/4885MEN1 2457/4885P4HB 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.